.png){kind=small}
MEN’S HORMONE HEALTH
Testosterone, DHT and Hair Loss: Causes, Evaluation and Treatment Options
Hair thinning during testosterone therapy deserves an evaluation. Hormones, inherited follicle sensitivity and other causes can overlap.
Medically reviewed by Dr. Timothy Mackey
Medical Director, NovaGenix
Updated September 2026
The short answer
Testosterone can contribute to male-pattern hair loss through conversion to DHT, but genetics and follicle sensitivity matter. A high blood testosterone level is not required, and thinning hair does not prove a hormone imbalance.
TRT may accelerate pattern thinning in susceptible men. It does not cause every type of shedding, and not every man taking TRT will lose scalp hair. The first step is identifying the type of hair loss.
Testosterone, DHT and follicle sensitivity
Testosterone → DHT
The enzyme 5-alpha reductase converts testosterone into dihydrotestosterone (DHT). DHT is a distinct androgen, not the “free” portion of total testosterone.
Sensitive scalp follicles
In genetically susceptible follicles, androgen signaling contributes to progressively finer, shorter hairs. This process is called miniaturization.
Total testosterone includes bound and unbound testosterone; free testosterone is the unbound fraction. A blood measurement does not directly measure a scalp follicle’s response. MedlinePlus Genetics explains the inherited and androgen-related basis of pattern hair loss.
Does high testosterone cause baldness?
There is no simple blood-testosterone threshold that predicts baldness. Male-pattern hair loss can occur with normal circulating hormone levels. Genetics involve multiple factors, so family history on either side can be relevant.
Scalp follicles respond differently from facial and body-hair follicles. Having a beard and thinning scalp hair is therefore not a contradiction, nor a diagnostic test for testosterone excess.
Can TRT speed up hair loss?
TRT increases androgen exposure and may accelerate thinning in men already susceptible to androgenetic alopecia. The timing and degree of change vary; a personal risk percentage cannot be determined from a routine hormone panel.
If thinning appears after starting or changing treatment, discuss the timeline with the prescriber. Review the reason for TRT, monitoring results and other recent changes. An illness, substantial weight loss or another medicine may also explain shedding.
Do not stop TRT or add a DHT-lowering medicine on your own. There is no universally hair-safe testosterone dose or formulation. The medical goal remains appropriate treatment of confirmed deficiency, with unwanted effects addressed individually. See our TRT overview and guide to testosterone therapy side effects for the broader treatment and monitoring context.
Pattern thinning is different from sudden shedding
| What you notice | What evaluation considers |
|---|---|
| Gradual recession or thinning at the crown | Androgenetic alopecia is a common possibility. |
| Diffuse shedding after illness, surgery, weight loss or stress | Telogen effluvium and other triggers; shedding may appear months after the event. |
| Distinct patches of loss | Alopecia areata, infection or other conditions requiring examination. |
| Pain, inflammation, marked scale or scarring | Inflammatory or scarring disease that should be assessed promptly. |
More than one cause can be present. A photograph or a hormone result alone may not distinguish them.
How hair loss is evaluated
A clinician asks about onset, progression, family history, medicines, nutrition, recent illness and scalp symptoms. Examination may include magnified assessment of the scalp and hair shafts. Consistent photographs can help document changes over time.
A dermatologist can distinguish pattern loss from shedding, inflammation and scarring. Selected blood tests or a scalp biopsy may be appropriate when the history and examination suggest another cause. The American Academy of Dermatology describes this diagnostic process.
Do you need testosterone or DHT blood tests?
Typical male-pattern hair loss is often diagnosed clinically. Routine DHT testing is not a required first step for everyone, and a normal result cannot rule out inherited follicle sensitivity.
Testosterone testing is considered when symptoms or medical history suggest deficiency or another hormone disorder—not simply because a hairline is receding. Thyroid testing, iron studies or other tests may be selected for diffuse shedding or relevant clinical findings.
For men already receiving TRT, review monitoring results with the prescriber. Neither a blood DHT target nor a genetic test can guarantee that hair loss will not progress. Read more about testosterone testing and interpreting hormone results.
Treatment options: match the treatment to the diagnosis
For confirmed male-pattern hair loss, treatments may slow progression or improve growth, but they do not work equally well for everyone. Benefits usually take months to assess, and continued treatment is often needed. These are options to discuss with a qualified clinician, not a statement that NovaGenix provides every listed treatment.
Topical minoxidil
FDA-approved topical minoxidil products are available for pattern hair loss. Minoxidil is a medication; it does not work by blocking DHT. Scalp irritation and an early change in shedding can occur. Follow the product instructions and discuss persistent unwanted effects. AAD’s male-pattern hair loss guide explains expected benefits and ongoing use.
Oral finasteride
Oral finasteride is FDA-approved for male-pattern hair loss in men. It reduces conversion of testosterone to DHT. Discuss potential sexual adverse effects, mood symptoms and fertility concerns with the prescriber. Persistent sexual symptoms have been reported after discontinuation; spontaneous reports do not establish how often they occur.
Finasteride lowers PSA and affects interpretation of that test, so every clinician interpreting your PSA should know you take it. Pregnant people should not handle crushed or broken tablets. See the prescribing information for complete risks and precautions.
Compounded topical finasteride
Topical application does not guarantee that a medicine stays only in the scalp. The FDA warns that compounded topical finasteride products are not FDA-approved and can have systemic effects and unintended transfer risks. Review handling precautions and potential exposure to others.
Other options
Oral minoxidil is used off-label for hair loss and requires medical assessment, including consideration of blood pressure and cardiovascular history. AAD discusses clinician-selected treatment options. Other off-label drugs, devices and hair transplantation have different indications and limitations; a dermatologist can help assess suitability.
Should every patient on TRT take a DHT blocker?
No. Automatically adding another medication exposes patients to risks without establishing that it is needed. First confirm the diagnosis, review the hormone treatment and discuss the patient’s priorities.
DHT has normal physiological roles. Treatment should not aim to drive a laboratory value as low as possible. Decisions about hair preservation, sexual symptoms, fertility and ongoing TRT should be coordinated between the prescribing clinician and dermatologist.
Can stopping TRT reverse hair loss?
Stopping treatment is not a guaranteed way to restore hair. Established pattern loss may persist, and stopping medically indicated testosterone can allow deficiency symptoms to return.
Regrowth also depends on the diagnosis: temporary shedding may improve after its trigger resolves, while scarring hair loss can be permanent. Get a diagnosis before assuming a medication change will solve the problem.
When to seek a dermatology evaluation
Arrange prompt assessment for sudden patchy loss, scalp pain, redness, pustules, substantial scaling or signs of scarring. Progressive thinning is also worth addressing early because treatment may help preserve existing hair.
Bring a medication and supplement list, dated photographs and any hormone results. Avoid starting multiple products simultaneously without guidance; that makes benefits and adverse effects harder to interpret.
Frequently asked questions
Does TRT make every man go bald?
No. Susceptibility varies. TRT may accelerate pattern thinning in some men, but other causes of hair loss still need consideration.
Can DHT cause hair loss when testosterone is normal?
Yes. Follicle sensitivity and local androgen signaling matter; normal blood testosterone does not exclude androgenetic alopecia.
Is free testosterone the same as DHT?
No. Free testosterone is unbound testosterone. DHT is a separate androgen produced from testosterone.
Should I have a DHT test before starting TRT?
It is not a universal requirement for predicting hair loss. Discuss your history and concerns with the prescriber; a test cannot guarantee hair preservation.
Can I take finasteride while on TRT?
Some patients may be considered for both, but the decision requires an individualized discussion of the hair-loss diagnosis, adverse effects, PSA interpretation and treatment goals.
Is topical finasteride free of systemic side effects?
No. Absorption and systemic effects can occur, and compounded topical products are not FDA-approved.
How long does hair-loss treatment take?
Visible changes generally require months. The clinician should set a follow-up plan appropriate to the treatment; no option guarantees regrowth.
Discuss hair changes during hormone treatment
At NovaGenix in Jupiter, Dr. Timothy Mackey can review hair changes alongside your hormone treatment and determine whether dermatology assessment is appropriate. A consultation can clarify the next steps without assuming every scalp concern is a testosterone problem.
